Nothing Special   »   [go: up one dir, main page]

ES2522908T3 - Composiciones a base de compuestos policíclicos con puente para la inhibición y el alivio de enfermedades - Google Patents

Composiciones a base de compuestos policíclicos con puente para la inhibición y el alivio de enfermedades Download PDF

Info

Publication number
ES2522908T3
ES2522908T3 ES08730417.6T ES08730417T ES2522908T3 ES 2522908 T3 ES2522908 T3 ES 2522908T3 ES 08730417 T ES08730417 T ES 08730417T ES 2522908 T3 ES2522908 T3 ES 2522908T3
Authority
ES
Spain
Prior art keywords
group
substituted
alkyl
aryl group
heterocycle
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES08730417.6T
Other languages
English (en)
Inventor
Jeffery A. Whiteford
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AllAccem Inc
Original Assignee
AllAccem Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by AllAccem Inc filed Critical AllAccem Inc
Application granted granted Critical
Publication of ES2522908T3 publication Critical patent/ES2522908T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/547—Chelates, e.g. Gd-DOTA or Zinc-amino acid chelates; Chelate-forming compounds, e.g. DOTA or ethylenediamine being covalently linked or complexed to the pharmacologically- or therapeutically-active agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nanotechnology (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Virology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Image Processing (AREA)

Abstract

Una composición química que comprende: un compuesto químico, en el que el compuesto químico comprende una estructura general (Ia) o (I): en la que cada R1 es, de forma independiente, un grupo alquil-arilo, un grupo alquil-arilo sustituido, un grupo alquilo, un grupo alquilo sustituido, un grupo arilo, un grupo arilo sustituido, N, N+H N+R3, un grupo heterociclo, o un grupo heterociclo sustituido; en la que cada R2 es, de forma independiente, un grupo alquil-arilo, un grupo alquil-arilo sustituido, un grupo alquilo, un grupo alquilo sustituido, un grupo arilo, un grupo arilo sustituido, un grupo heterociclo o un grupo heterociclo sustituido, un enlace covalente, o un alqueno; en la que cada R3 es, de forma independiente, hidrógeno, un agente farmacéuticamente activo, un grupo alquil-arilo, un grupo alquil-arilo sustituido, un grupo alquilo, un grupo alquilo sustituido, un grupo arilo, un grupo arilo sustituido, un grupo heterociclo, un grupo heterociclo sustituido, un alqueno, un éter, un resto guanidina, un PEG, un PEI, o cualquier combinación de estos, donde al menos dos R3 son agentes farmacéuticamente activos, y donde el agente farmacéuticamente activo está configurado para inhibir y/o aliviar al menos una dolencia; en la que cada R4 es, de forma independiente, un grupo alquil-arilo, un grupo alquil-arilo sustituido, un grupo alquilo, un grupo alquilo sustituido, un grupo arilo, un grupo arilo sustituido, un grupo heterociclo o un grupo heterociclo sustituido, un éter, una amida, un alcohol, un éster, una sulfonamida, una sulfanilamida o un alqueno; en la que Z comprende al menos un puente, donde al menos uno de los puentes es - R2-N+R3 2-R4-N+R3 2-R2-, -R2-NR3-R4-N+R3 2-R2-, -R2-NR3-R4-NR3-R2- o -R2-N>=R4>=N-R2-, y donde cada puente acopla independientemente R1 a R1; y en la que X comprende al menos un contraion.

Description

imagen1
imagen2
imagen3
imagen4
imagen5
imagen6
imagen7
imagen8
imagen9
imagen10
imagen11
imagen12
imagen13
imagen14
imagen15
imagen16
imagen17
imagen18
imagen19
imagen20
imagen21
imagen22
imagen23
imagen24
imagen25
imagen26
imagen27
imagen28
imagen29
imagen30
imagen31
imagen32
imagen33
imagen34
imagen35
imagen36
imagen37
imagen38
imagen39
imagen40
imagen41
imagen42
imagen43
imagen44
imagen45
imagen46
imagen47
imagen48
imagen49
imagen50
imagen51
imagen52
imagen53
imagen54
imagen55
imagen56
imagen57
imagen58
imagen59
imagen60
imagen61
imagen62
imagen63
imagen64
imagen65
imagen66

Claims (1)

  1. imagen1
    imagen2
    imagen3
    imagen4
ES08730417.6T 2007-02-21 2008-02-21 Composiciones a base de compuestos policíclicos con puente para la inhibición y el alivio de enfermedades Active ES2522908T3 (es)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US90257707P 2007-02-21 2007-02-21
US902577P 2007-02-21
US96431207P 2007-08-10 2007-08-10
US964312P 2007-08-10
US96515407P 2007-08-17 2007-08-17
US965154P 2007-08-17
US2933208P 2008-02-16 2008-02-16
US29332 2008-02-16
PCT/US2008/054611 WO2008103847A2 (en) 2007-02-21 2008-02-21 Bridged polycyclic compound based compositions for the inhibition and amelioration of disease

Publications (1)

Publication Number Publication Date
ES2522908T3 true ES2522908T3 (es) 2014-11-19

Family

ID=39511053

Family Applications (1)

Application Number Title Priority Date Filing Date
ES08730417.6T Active ES2522908T3 (es) 2007-02-21 2008-02-21 Composiciones a base de compuestos policíclicos con puente para la inhibición y el alivio de enfermedades

Country Status (8)

Country Link
US (2) US8222239B2 (es)
EP (1) EP2125026B1 (es)
AU (1) AU2008218275B2 (es)
CA (1) CA2683383C (es)
DK (1) DK2125026T3 (es)
ES (1) ES2522908T3 (es)
NZ (1) NZ579785A (es)
WO (1) WO2008103847A2 (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007070801A2 (en) 2005-12-12 2007-06-21 Allaccem, Inc. Methods and systems for preparing antimicrobial films and coatings
WO2008103847A2 (en) 2007-02-21 2008-08-28 Allaccem, Incorporated Bridged polycyclic compound based compositions for the inhibition and amelioration of disease
US8153617B2 (en) 2007-08-10 2012-04-10 Allaccem, Inc. Bridged polycyclic compound based compositions for coating oral surfaces in humans
US8188068B2 (en) 2007-08-10 2012-05-29 Allaccem, Inc. Bridged polycyclic compound based compositions for coating oral surfaces in pets
US8153618B2 (en) 2007-08-10 2012-04-10 Allaccem, Inc. Bridged polycyclic compound based compositions for topical applications for pets
US8766004B2 (en) 2010-01-13 2014-07-01 The Research Foundation Of State University Of New York Green synthesis of aryl aldimines using ethyl lactate
TWI532487B (zh) 2011-10-21 2016-05-11 艾伯維有限公司 治療ｃ型肝炎病毒（ｈｃｖ）之方法
MX2014004729A (es) 2011-10-21 2014-07-28 Abbvie Inc Tratamiento en combinacion (por ejemplo, con abt-072 o abt-333) de agentes antivirales de accion directa para utilizarse en el tratamiento del virus de la hepatitis c.
US8466159B2 (en) 2011-10-21 2013-06-18 Abbvie Inc. Methods for treating HCV
US8492386B2 (en) 2011-10-21 2013-07-23 Abbvie Inc. Methods for treating HCV
US8883857B2 (en) 2012-12-07 2014-11-11 Baylor College Of Medicine Small molecule xanthine oxidase inhibitors and methods of use
EP3448392A4 (en) 2016-04-28 2020-01-15 Emory University ALCYNE-CONTAINING NUCLEOTIDES AND NUCLEOSIDES THERAPEUTIC COMPOSITIONS AND USES THEREOF
BR112021008767A2 (pt) * 2018-11-05 2021-08-17 The University Of Chicago métodos e composições para o tratamento de doença infecciosa, autoimune e alérgica
EP3876737A4 (en) * 2018-11-08 2021-12-29 Hwang-Hsing Chen Tris-substituted biguanide compounds and their uses

Family Cites Families (118)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB599722A (en) 1946-01-30 1948-03-18 Thomas Skeffington Kenny Aryl-dicyandiamides
US2455807A (en) 1945-09-11 1948-12-07 American Cyanamid Co Preparation of substituted cyanoguanidine
US3066112A (en) 1959-01-30 1962-11-27 Rafael L Bowen Dental filling material comprising vinyl silane treated fused silica and a binder consisting of the reaction product of bis phenol and glycidyl acrylate
US3179623A (en) 1959-01-30 1965-04-20 Rafael L Bowen Method of preparing a monomer having phenoxy and methacrylate groups linked by hydroxy glyceryl groups
CA878004A (en) 1968-06-14 1971-08-10 Ii Henry L. Lee Dental filling package
US3751399A (en) * 1971-05-24 1973-08-07 Lee Pharmaceuticals Polyacrylate resin compositions
US4321268A (en) * 1979-02-08 1982-03-23 Merz & Co. Certain substituted phenyl esters of nicotinic acid, compositions and methods of using same
US4666896A (en) 1979-04-26 1987-05-19 Bristol-Myers Company Chlorhexidine salts and compositions of same
US5753268A (en) 1982-06-03 1998-05-19 Dcv Biologics, L.P. Anti-cholesterolemic egg, vaccine and method for production, and use
US4544359A (en) 1984-01-13 1985-10-01 Pentron Corporation Dental restorative material
US4547531A (en) 1984-08-02 1985-10-15 Pentron Corporation Two component (paste-paste) self-curing dental restorative material
US5276068A (en) 1985-03-29 1994-01-04 Jeneric/Pentron, Inc. Dental resin materials
DE3608745A1 (de) 1985-07-24 1987-01-29 Bayer Ag Bakterizide zubereitungen zur anwendung auf dem gebiet der veterinaermedizin
US4853987A (en) * 1987-09-14 1989-08-08 Jaworski William R Unitized hydrotherapy jet and pump assembly
US4946942A (en) 1988-03-11 1990-08-07 Bioresearch, Inc. Urethane-protected amino acid-N-carboxyanhydrides
US5230842A (en) * 1989-02-21 1993-07-27 Munde Bruce A Interior pipeline coating process
CA1316623C (en) * 1989-04-06 1993-04-20 Pavel Stovicek Biocidal surface coating and casting compositions based on quarternary ammonium salts of nalkyl x,x bis (4,4' hydroxyphenyl) and quarternary salts of polyglycols as backbones of resins
US5158766A (en) * 1989-04-13 1992-10-27 Ecolab, Inc. Storage stable aqueous soluble germicidal film forming composition
US5064613A (en) * 1989-11-03 1991-11-12 Dow Corning Corporation Solid antimicrobial
GB9000564D0 (en) * 1990-01-10 1990-03-14 Dow Rheinmuenster Modified polyoxyethlene epoxy resin amphiphiles and stable aqueous epoxy dispersions thereof
US5348988A (en) * 1990-04-12 1994-09-20 Bisco, Inc. Dentin bonding system
US5344856A (en) * 1990-12-17 1994-09-06 The Dow Chemical Company Water-emulsifiable epoxy resin composition
US5212318A (en) * 1991-03-04 1993-05-18 Eastman Kodak Company Preparation of omega-substituted alkanamide
DE69223902T2 (de) * 1991-10-18 1998-08-27 Kuraray Co Antimikrobielle polymerisierbare Zusammensetzung, das Polymer und daraus hergestellter Gegenstand
US5386018A (en) * 1991-12-31 1995-01-31 Lever Brothers Company, Division Of Conopco, Inc. Process of preparing N-substituted aldonamides
US5248742A (en) * 1992-04-27 1993-09-28 Gencorp Inc. Unsaturated polyester-epoxy resin network composition
DE4222821C2 (de) 1992-07-08 1994-09-22 Ivoclar Ag Modifiziertes Chlorhexidin-Addukt
CA2151834A1 (en) 1992-12-21 1994-07-07 Alliedsignal Inc. Solvent free epoxy resin compositions
US5667775A (en) 1993-08-11 1997-09-16 Geltex Pharmaceuticals, Inc. Phosphate-binding polymers for oral administration
US5496545A (en) 1993-08-11 1996-03-05 Geltex Pharmaceuticals, Inc. Phosphate-binding polymers for oral administration
US5389703A (en) * 1993-10-12 1995-02-14 Air Products And Chemicals, Inc. Method of making hybrid polymer of epoxy resin and the resulting product
US5414878A (en) * 1993-11-03 1995-05-16 Sanijet Corporation Sanitary whirlpool jet apparatus
ES2079320B1 (es) 1994-05-17 1996-10-16 Cusi Lab Disolucion oftalmica a base de un diclofenaco y tobramicina y sus aplicaciones.
AUPM623994A0 (en) 1994-06-15 1994-07-07 Biomolecular Research Institute Limited Antiviral dendrimers
US5521246A (en) * 1994-07-25 1996-05-28 Air Products And Chemicals, Inc. Low temperature self-crosslinking aqueous urethane-vinyl polymers for coating applications
ES2143644T3 (es) 1994-08-02 2000-05-16 Procter & Gamble Procedimiento para elaborar compuestos antimicrobianos.
US5698657A (en) * 1995-05-09 1997-12-16 Air Products And Chemicals, Inc. Flexibilizing epoxy resins with low molecular weight acrylate copolymers
US6500004B2 (en) * 2000-12-14 2002-12-31 Ultradent Products, Inc. Endodontic sealing compositions and methods for using such compositions
US5874516A (en) * 1995-07-13 1999-02-23 Air Products And Chemicals, Inc. Nonfunctionalized poly(arylene ethers)
US5658994A (en) * 1995-07-13 1997-08-19 Air Products And Chemicals, Inc. Nonfunctionalized poly(arylene ether) dielectrics
US5602193A (en) * 1995-10-31 1997-02-11 Shell Oil Company Aqueous dispersions of epoxy resins
US5753269A (en) 1995-12-27 1998-05-19 Bayer Corporation Otic microbial combinations
ATE210629T1 (de) * 1996-03-14 2001-12-15 Warner Lambert Co Verbrückte zyklische aminosäuren als pharmazeutische mittel
US5925552A (en) 1996-04-25 1999-07-20 Medtronic, Inc. Method for attachment of biomolecules to medical devices surfaces
US5824734A (en) * 1996-07-10 1998-10-20 Air Products And Chemicals, Inc. Waterborne coating compositions
US6080170A (en) * 1996-07-26 2000-06-27 Kensey Nash Corporation System and method of use for revascularizing stenotic bypass grafts and other occluded blood vessels
CA2278656C (en) 1997-01-28 2009-09-08 Stepan Company Improved emulsion polymerization process utilizing ethylenically unsaturated amine salts of sulfonic, phosphoric and carboxylic acids
US6242526B1 (en) * 1997-01-28 2001-06-05 Stepan Company Antimicrobial polymer latexes derived from unsaturated quaternary ammonium compounds and antimicrobial coatings, sealants, adhesives and elastomers produced from such latexes
DE19709076A1 (de) * 1997-03-06 1998-09-10 Huels Chemische Werke Ag Verfahren zur Herstellung antimikrobieller Kunststoffe
US6416546B1 (en) * 1997-06-04 2002-07-09 Unitika Ltd. Medical device and production method thereof
KR100291482B1 (ko) * 1997-06-24 2001-06-01 시부키 유키오 이산화티탄 결정배향막을 갖는 재료 및 그 제조방법
US5990110A (en) 1997-07-15 1999-11-23 Bristol-Meyers Squibb Company Method for treating tumors having high LDL requirements employing MTP inhibitors
US5948390A (en) 1997-08-25 1999-09-07 Pfizer Inc. Stable zinc/citrate/CPC oral rinse formulations
US6060235A (en) 1997-09-19 2000-05-09 Geltex Pharmaceuticals, Inc. Antiviral polymers comprising acid functional groups and hydrophobic groups
WO1999020227A1 (en) 1997-10-22 1999-04-29 Dentsply International Inc. Protective varnish for dentin
US6008313A (en) * 1997-11-19 1999-12-28 Air Products And Chemicals, Inc. Polyamide curing agents based on mixtures of polyethyleneamines and piperazine derivatives
US6436419B1 (en) * 1998-09-11 2002-08-20 The Regents Of The University Of California Antimicrobial treatment of polymers
AUPP584298A0 (en) 1998-09-14 1998-10-08 Starpharma Limited Antimicrobial and antiparasitic agents
US6187248B1 (en) * 1998-11-19 2001-02-13 Air Products And Chemicals, Inc. Nanoporous polymer films for extreme low and interlayer dielectrics
US7709694B2 (en) 1998-12-08 2010-05-04 Quick-Med Technologies, Inc. Materials with covalently-bonded, nonleachable, polymeric antimicrobial surfaces
FR2789591B1 (fr) 1999-02-17 2002-10-04 Rhodia Chimie Sa Utilisation de dispersions filmogenes de dioxyde de titane pour la desinfection des surfaces dures, dispersions filmogenes de dioxyde de titane et procede de desinfection
US6350397B1 (en) 1999-03-10 2002-02-26 Aspen Research Corporation Optical member with layer having a coating geometry and composition that enhance cleaning properties
US6218455B1 (en) * 1999-05-19 2001-04-17 Air Products Polymers, L.P. Vinyl acetate/ethylene paint latices stabilized with urethane linked poly(ethylene glycols) and polyoxyethylene-polyoxyalkylene glycols
US6440405B1 (en) 1999-06-07 2002-08-27 University Of Delaware Quaternary ammonium functionalized dendrimers and methods of use therefor
US6235811B1 (en) * 1999-06-08 2001-05-22 Air Products And Chemicals, Inc. Epoxy resin-vinyl acetate polymer blends
US6608131B1 (en) * 1999-07-20 2003-08-19 Weyerhaeuser Company Edge sealant formulation for wood-based panels
US6458876B1 (en) * 1999-08-09 2002-10-01 Air Products And Chemicals, Inc. Ink jet paper coatings containing polyvinyl alcohol-alkylated polyamine blends
US6455134B1 (en) * 1999-08-26 2002-09-24 Air Products Polymers, L.P. Ink jet media comprising a coating containing amine functional emulsion polymers
US6326417B1 (en) 1999-10-21 2001-12-04 Jeneric/Pentron Incorporated Anti-microbial dental compositions and method
US6267590B1 (en) * 1999-11-24 2001-07-31 Agion Technologies, Llc Antimicrobial dental products
US20020051754A1 (en) * 2000-04-13 2002-05-02 Schroeder Joseph D. Anti-microbial packaging polymer and its method of use
US7067346B2 (en) 2000-06-06 2006-06-27 Simon Foster University Titanium carboxylate films for use in semiconductor processing
US6538143B1 (en) * 2000-06-26 2003-03-25 Air Products Polymers, L.P. Wet adhesion monomer and derived copolymers for latex paints
CA2416900C (en) 2000-07-28 2007-07-03 F. Hoffmann-La Roche Ag The use of a combination of a lipase inhibitor and a pharmaceutically acceptable bile acid sequestrant for the prevention and treatment of diseases associated with high plasma cholesterol levels
EP1307264B1 (en) 2000-07-28 2004-10-20 F. Hoffmann-La Roche Ag New pharmaceutical composition
US7365118B2 (en) 2003-07-08 2008-04-29 Los Alamos National Security, Llc Polymer-assisted deposition of films
US6468953B1 (en) * 2000-08-03 2002-10-22 Lynntech, Inc. Methods of preparing antimicrobial compositions comprising ozone
US7275932B2 (en) 2001-09-20 2007-10-02 Pentron Clinical Technologies, Llc Self-curing system for endodontic sealant applications
US6309221B1 (en) * 2000-10-13 2001-10-30 Ultradent Products, Inc. Compositions, methods and kits for hemostasis and sealing of pulp during invasive dental procedures
EP2324861A1 (en) 2000-11-20 2011-05-25 Sorbent Therapeutics, Inc. In vivo use of water absorbent polymers
WO2002048100A2 (de) 2000-12-15 2002-06-20 Bayer Aktiengesellschaft Thiosulfonsäure-s-ester als materialschutzmittel
EP1368439B1 (en) * 2001-03-15 2012-01-25 Cabot Corporation Matt, thixotropic paint formulation
US6632291B2 (en) * 2001-03-23 2003-10-14 Ecolab Inc. Methods and compositions for cleaning, rinsing, and antimicrobial treatment of medical equipment
US7151139B2 (en) 2001-04-23 2006-12-19 Massachusetts Institute Of Technology Antimicrobial polymeric surfaces
US6929705B2 (en) * 2001-04-30 2005-08-16 Ak Steel Corporation Antimicrobial coated metal sheet
US6593395B2 (en) 2001-05-16 2003-07-15 Kerr Corporation Dental composition containing discrete nanoparticles
US6716955B2 (en) * 2002-01-14 2004-04-06 Air Products And Chemicals, Inc. Poly(arylene ether) polymer with low temperature crosslinking grafts and adhesive comprising the same
US6838500B2 (en) 2002-02-07 2005-01-04 Carlisle Stuart D Adhesive compositions and tapes comprising same
US6673958B2 (en) * 2002-02-07 2004-01-06 Bisco, Inc. Multifunctional dentin bonding agent
DE10210027A1 (de) 2002-03-07 2003-09-18 Creavis Tech & Innovation Gmbh Hydrophile Oberflächen
US20030199605A1 (en) * 2002-04-23 2003-10-23 Fischer Dan E. Hydrophilic endodontic sealing compositions and methods for using such compositions
CN1218634C (zh) 2002-04-30 2005-09-14 香港中文大学 具有高杀菌光活性介孔二氧化钛薄膜的制备方法
US6887517B1 (en) * 2002-06-12 2005-05-03 Tda Research Surface modified particles by multi-step Michael-type addition and process for the preparation thereof
US6924325B2 (en) 2002-06-21 2005-08-02 Kerr Corporation Silver-containing dental composition
US20050008763A1 (en) 2002-09-24 2005-01-13 Schachter Steven C. Antimicrobial coatings for medical applications
US20040092896A1 (en) 2002-11-13 2004-05-13 Thompson Kaila R. Antimicrobial sheets for environmental and human protection
US20040199994A1 (en) 2003-04-10 2004-10-14 Fatima Sherif Pedicure tub liner
US7498432B2 (en) 2003-06-25 2009-03-03 Board Of Trustees Of Michigan State University Method of synthesis of 1, 4, 7, 10, 13, 16, 21, 24-octaazabicyclo [8.8.8] hexacosane (1) and 1, 4, 7, 10, 13, 16, 21, 24-octaazabicyclo [8.8.8] hexacosa, 4, 6, 13, 15, 21, 23-hexaene (2)
EP2279722B1 (en) * 2003-08-12 2013-05-01 3M Innovative Properties Company Self-etching dental compositions and its use
US7314857B2 (en) * 2003-08-25 2008-01-01 Kane Biotech Inc. Synergistic antimicrobial compositions and methods of inhibiting biofilm formation
US7385012B2 (en) * 2003-11-03 2008-06-10 Ilypsa, Inc. Polyamine polymers
JP2005154379A (ja) 2003-11-28 2005-06-16 Konishi Kagaku Ind Co Ltd ４、４’−ジビニル置換芳香族化合物の製造方法
US6936640B2 (en) 2003-12-04 2005-08-30 Alcon, Inc. Biguanide/quaternary ammonium containing copolymeric biocides and use thereof in pharmaceutical compositions
US20050129937A1 (en) * 2003-12-16 2005-06-16 Eastman Kodak Company Antimicrobial web for application to a surface
WO2005063184A1 (en) 2003-12-22 2005-07-14 Imrex, Inc. Methods and compositions for oral hygiene
US20050208249A1 (en) 2004-03-19 2005-09-22 Sika Automotive Curable elastomeric adhesive compositions
US20050249818A1 (en) 2004-05-03 2005-11-10 Sawan Samuel P Polycationic antimicrobial therapeutic
US7156911B2 (en) 2004-05-17 2007-01-02 3M Innovative Properties Company Dental compositions containing nanofillers and related methods
US7649029B2 (en) * 2004-05-17 2010-01-19 3M Innovative Properties Company Dental compositions containing nanozirconia fillers
JP3932293B2 (ja) * 2005-09-08 2007-06-20 旭有機材工業株式会社 発泡性レゾール型フェノール樹脂成形材料およびフェノール樹脂発泡体
WO2007070801A2 (en) * 2005-12-12 2007-06-21 Allaccem, Inc. Methods and systems for preparing antimicrobial films and coatings
WO2008103847A2 (en) 2007-02-21 2008-08-28 Allaccem, Incorporated Bridged polycyclic compound based compositions for the inhibition and amelioration of disease
US8188068B2 (en) * 2007-08-10 2012-05-29 Allaccem, Inc. Bridged polycyclic compound based compositions for coating oral surfaces in pets
US8153618B2 (en) * 2007-08-10 2012-04-10 Allaccem, Inc. Bridged polycyclic compound based compositions for topical applications for pets
US8153617B2 (en) * 2007-08-10 2012-04-10 Allaccem, Inc. Bridged polycyclic compound based compositions for coating oral surfaces in humans
US20090074833A1 (en) * 2007-08-17 2009-03-19 Whiteford Jeffery A Bridged polycyclic compound based compositions for controlling bone resorption
US20100004218A1 (en) * 2008-06-20 2010-01-07 Whiteford Jeffery A Bridged polycyclic compound based compositions for renal therapy
US20100016270A1 (en) * 2008-06-20 2010-01-21 Whiteford Jeffery A Bridged polycyclic compound based compositions for controlling cholesterol levels

Also Published As

Publication number Publication date
EP2125026B1 (en) 2014-09-24
WO2008103847A2 (en) 2008-08-28
US20130040924A1 (en) 2013-02-14
EP2125026A2 (en) 2009-12-02
US8222239B2 (en) 2012-07-17
DK2125026T3 (en) 2014-12-08
US20080275141A1 (en) 2008-11-06
CA2683383A1 (en) 2008-08-28
AU2008218275A1 (en) 2008-08-28
WO2008103847A3 (en) 2008-11-20
AU2008218275B2 (en) 2013-06-20
US9994444B2 (en) 2018-06-12
NZ579785A (en) 2012-06-29
CA2683383C (en) 2016-01-05

Similar Documents

Publication Publication Date Title
ES2522908T3 (es) Composiciones a base de compuestos policíclicos con puente para la inhibición y el alivio de enfermedades
UY30603A1 (es) Derivados de 2-aril-6-fenil-imidazo[1, 2-a]piridinas, su preparacion y su aplicacion en terapéutica
AR029216A1 (es) Compuestos inhibidores no peptidicos de la union celular dependiente de vla-4 utiles en el tratamiento de enfermedades inflamatorias, autoinmunes y respiratorias; composicion farmaceutica y procedimiento de tratamiento
CO5560559A2 (es) Formulacion de suspension oral estabilizada
AR063707A1 (es) Determinadas amidas sustituidas, el uso de las mismas para el tratamiento de enfermedades mediadas por la inhibicion de la actividad de btk y composiciones farmacéuticas que las comprenden.
CY1118321T1 (el) Συστημα διαλυτων για βελτιωση της διαλυτοτητας των φαρμακευτικων παραγοντων
HUP0301607A2 (hu) Szelektív neurokinin antagonista hatású nitrogéntartalmú heterociklusos vegyületek, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
PE20030865A1 (es) Composiciones farmaceuticas para inhibidores de proteasa viral de la hepatitis c
ECSP109932A (es) Compuestos de biciclolactama sustituida
ECSP066968A (es) Compuestos de metil-aril o heteroaril-amida sustituida
BRPI0509471A (pt) lipìdios, complexos de lipìdio e uso dos mesmos
PE20090042A1 (es) Analogos de ciclopamina
DOP2005000076A (es) "compuestos de aril-o heteroarilamida ortosustituidos"
BRPI0707491B8 (pt) compostos úteis como agentes moduladores de receptores de mineralocorticóides, os referidos agentes compreendendo os mesmos e composições farmacêuticas
TW200745058A (en) MMP-13 selective inhibitors
AR031597A1 (es) Compuestos piperidinos,un proceso para su preparacion, composiciones farmaceuticas,y el uso de dichos compuestos para la fabricacion de un medicamento para uso como inhibidores ccr-3
AR042941A1 (es) Derivados de tiazol, su preparacion, composiciones farmaceuticas que los contienen y su uso en la fabricacion de medicamentos inhibidores de la proteina-1 de adhesion vascular (vap-1)
ECSP077402A (es) Derivados de 2-amido-4-feniltiazol, su preparación y su aplicación en terapéutica
AR028914A1 (es) 2-guanidino-4-aril-quinazolinas como inhibidores de nhe-3
AR058180A1 (es) Indeno derivados, su preparacion y su uso como medicamentos
RU2005105564A (ru) Производные бензимидазола и их применение в качестве пролекарств ингибиторов протонного насоса
ECSP088457A (es) Compuestos de benzamida útiles como inhibidores de la histona deacetilasa
AR049401A1 (es) Aza-biciclononanos
AR012426A1 (es) Un compuesto de indazol amida, un procedimiento para prepararlo, compuestos intermediarios, y una composicion farmaceutica que comprende dicho compuesto de indazol amida.
UY28848A1 (es) Antagonistas de cgrp seleccionados, procedimientos para su preparación, y su empleo como medicamentos